하민진 교수

보건대학원

  • 전공

    Biostatistics

  • 연구실

    종합관 323

  • 전화/팩스
  • 이메일

    mjha@yuhs.ac

학력

  • 덕성여자대학교 정보통계학과 (학사)
  • 서울대학교 통계학과 (석사)
  • University of North Carolina- Chapel Hill (박사)

경력

  • 2013.10-2016.04 텍사스주립대 MD Anderson Cancer Center 박사후 연구원
  • 2016.05-2022.02 텍사스주립대 MD Anderson Cancer Center 조교수
  • 2016.05-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences 조교수

학술활동

  • 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Quantitative Sciences curriculum committee 자문위원
  • 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Faculty Academic Review Committee, 자문위원
  • 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Department of Biostatistics, Faculty Search committee, 자문위원
  • 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Institutional Animal Care and Use Committee, 자문위원
  • 2016.05-2017.12 공동연구자, 미국국립보건원
  • (Title: Risk Prediction for ER-Negative Breast Cancer Recurrence)
  • 2016.05-2020.11 공동연구자, 미국국립보건원
  • (Title: Graph-based Bayesian Analysis of Genomics and Proteomics Data)
  • 2016.08-2020.08 공동연구자, Cancer Prevention & Research Institute of Texas
  • (Title: Acute Myeloid Leukemia in the Immunosuppressed Microenvironment)
  • 2016.08-2021.08 공동연구자, Cancer Prevention & Research Institute of Texas
  • (Title: A Randomized Clinical Trial Platform)
  • 2017.09-2021.08 공동연구자, 미국국립보건원
  • (Title: Cytoplasmic cyclin E is an early event for progression inva- sive breast cancer)
  • 2018.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas
  • (Title: Overcoming PARP inhibitor resistance in pa- tients with breast cancer who have germline BRCA mutations)
  • 2020.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas, 미국
  • (Title: Targeted Proteolysis of Glucocorticoid Receptor (GR) as a Therapeutic Strategy to Enhance Anti-Tumor Immunity)
  • 2019.10-2022.09 공동연구자, 미국국립보건원
  • (Title: Mechanisms and Vulnerabilities of SWI/SNF chromatin remod- eling complex mutant lung cancer)
  • 2016.08-2022.02 공동연구자, 미국국립보건원
  • (Title: SPORE: Targeting Lung Cancer Vulnerabilities)
  • 2018.08-2022.08 공동연구자, Cancer Prevention & Research Institute of Texas, 미국
  • (Title: Rational Combination Treatment Options to Reverse Resistance in Hormone Receptor Positive
  • Breast Cancer Refractory to Standard Therapy)
  • 2019.09-2022.02 공동연구자, The University of Texas MD Anderson Cancer Center
  • (Title: Therapeutic Targeting of DKK3 in Pancreatic Cancer and Response to Chemotherapy)
  • 2021.07-2022.02 공동연구자, 미국국립보건원
  • (Title: RNase H2 is a novel therapeutic target in triple negative breast cancer)
  • 2021.07-2022.02 공동연구자, Boehringer Ingelheim Pharm Inc
  • (Title: Targeting ROR1 Overexpressing Tumors with NBE-002)
  • 2016.09-2022.02 Biostatistician, Biostatistics Resource Group, 텍사스주립대 MD Anderson Cancer Center
  • 2016.09-2017.08 Biostatistician, Department of Breast Surgical Oncology, 텍사스주립대 MD Anderson Cancer Center
  • 2018.09-2022.02 디렉터, Biostatistics and Bioinformatics, Leukemia and Lymphoma Society, 미국
  • 2019.10-2022.02 디렉터, Data Science, 미국국립보건원 (University of Texas PDX Development and Trial Center)
  • 2018.07-2021.06 연구책임자, 미국국립보건원
  • (Title: Proteomic-based integrated subject-specific networks in cancer)
  • 2021.02-2022.02 연구책임자, 미국국립보건원
  • (Title: Bayesian Network-Based Integrative Ge- nomics Methods for Precision Medicine)

연구분야

  • Graphical Models
  • Bayesian Statistics
  • Causal Mediation Analysis
  • Machine Learning
  • Tensor Models
  • High-dimensional Statistics
  • Omic Data
  • Imaging data